Who
Gail Boxer Marcus
Director
Company insider
Files Form 4 as: Director, Natera; Director, Triple-S Management.
In numbers
- Trades disclosed
- 162
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $12.4M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 17 Apr 2017
- Last trade
- 26 Jun 2026
- Last filed
- 30 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 30 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —1,571 | filing |
| 26 Jun 2026filed 30 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —98 | filing |
| 26 Jun 2026filed 30 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —1,571 | filing |
| 26 Jun 2026filed 30 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —98 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code M | $251K11,000 at $22.83 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $652K3,016 at $216.06 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $1.0M4,694 at $217.30 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA Nateraoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,000 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $692K3,174 at $218.11 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $25K116 at $218.82 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA Nateraoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,000 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code M | $251K11,000 at $22.83 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $652K3,016 at $216.06 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $1.0M4,694 at $217.30 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $692K3,174 at $218.11 | filing |
| 5 Jun 2026filed 9 Jun 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $25K116 at $218.82 | filing |
| 24 Apr 2026filed 28 Apr 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —108 | filing |
| 24 Apr 2026filed 28 Apr 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —222 | filing |
| 24 Apr 2026filed 28 Apr 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —108 | filing |
| 24 Apr 2026filed 28 Apr 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —222 | filing |
News
ESMO 2026 Presentations Deepen the Evidence Base for Natera's Oncology Portfolio and Leadership in Ultrasensitive MRD Technology | wallstreetONLINENTRA · wallstreet-online.de · 19 Oct 2026Curated Wealth Partners LLC Purchases 2,195 Shares of Natera, Inc. $NTRANTRA · dailypolitical.com · 16 Oct 2026Natera, TransCode Target Residual Colorectal Cancer With Trial CollaborationNTRA · rttnews.com · 13 Oct 2026
0 headlines in the last 90 days name Gail Boxer Marcus; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.